Liver disease treatment market to be valued at $69.1b by 2030

Personalised medicine and fibrosis-targeting treatments are key growth areas.

The global liver disease treatment market is projected to reach $69.1b by 2030 at a compound annual growth rate of 7.1%, according to BCC Research LLC.

The sector’s expansion is attributed to the increasing demand for advanced therapies due to the rising prevalence of liver disease and biotech developments.

In line with this, personalised medicine and fibrosis-targeting treatments drive market growth.

Government initiatives, including vaccination programmes and public awareness campaigns, also influence the market.

“These efforts help prevent conditions like hepatitis and encourage early diagnosis and treatment, which boosts demand for healthcare services and supports market growth,” the report said.